Deplat contains the active ingredient Clopidogrel, a prodrug that is metabolized by CYP450 enzymes to an active substance that inhibits platelet aggregation. It is indicated for the prevention of atherothrombotic and atherothrombotic events in patients with atrial fibrillation.